Abstract
Objectives
To develop and validate a multiparametric MRI-based radiomics nomogram for pretreatment predicting the axillary sentinel lymph node (SLN) burden in early-stage breast cancer.
Methods
A total of 230 women with early-stage invasive breast cancer were retrospectively analyzed. A radiomics signature was constructed based on preoperative multiparametric MRI from the training dataset (n = 126) of center 1, then tested in the validation cohort (n = 42) from center 1 and an external test cohort (n = 62) from center 2. Multivariable logistic regression was applied to develop a radiomics nomogram incorporating radiomics signature and predictive clinical and radiological features. The radiomics nomogram’s performance was evaluated by its discrimination, calibration, and clinical use and was compared with MRI-based descriptors of primary breast tumor.
Results
The constructed radiomics nomogram incorporating radiomics signature and MRI-determined axillary lymph node (ALN) burden showed a good calibration and outperformed the MRI-determined ALN burden alone for predicting SLN burden (area under the curve [AUC]: 0.82 vs. 0.68 [p < 0.001] in training cohort; 0.81 vs. 0.68 in validation cohort [p = 0.04]; and 0.81 vs. 0.58 [p = 0.001] in test cohort). Compared with the MRI-based breast tumor combined descriptors, the radiomics nomogram achieved a higher AUC in test cohort (0.81 vs. 0.58, p = 0.005) and a comparable AUC in training (0.82 vs. 0.73, p = 0.15) and validation (0.81 vs. 0.65, p = 0.31) cohorts.
Conclusion
A multiparametric MRI-based radiomics nomogram can be used for preoperative prediction of the SLN burden in early-stage breast cancer.
Key Points
• Radiomics nomogram incorporating radiomics signature and MRI-determined ALN burden outperforms the MRI-determined ALN burden alone for predicting SLN burden in early-stage breast cancer.
• Radiomics nomogram might have a better predictive ability than the MRI-based breast tumor combined descriptors.
• Multiparametric MRI-based radiomics nomogram can be used as a non-invasive tool for preoperative predicting of SLN burden in patients with early-stage breast cancer.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-020-07674-z/MediaObjects/330_2020_7674_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-020-07674-z/MediaObjects/330_2020_7674_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-020-07674-z/MediaObjects/330_2020_7674_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-020-07674-z/MediaObjects/330_2020_7674_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-020-07674-z/MediaObjects/330_2020_7674_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-020-07674-z/MediaObjects/330_2020_7674_Fig6_HTML.png)
Similar content being viewed by others
Abbreviations
- ALN:
-
Axillary lymph node
- ALND:
-
Axillary lymph node dissection
- AUC:
-
Area under the curve
- CI:
-
Confidence interval
- DCE:
-
Dynamic contrast-enhanced
- DWI:
-
Diffusion-weighted imaging
- ER:
-
Estrogen receptor
- HER-2:
-
Human epidermal growth factor receptor-2
- ICC:
-
Intra-class correlation coefficient
- IDI:
-
Integrated discrimination improvement
- LASSO:
-
Least absolute shrinkage and selection operator
- NRI:
-
Net reclassification improvement
- PR:
-
Progesterone receptor
- pSLN:
-
Pathologic sentinel lymph node
- ROC:
-
Receiver operating characteristic
- SLN:
-
Sentinel lymph node
- T1+C:
-
Delayed contrast-enhanced T1-weighted imaging
- T1WI:
-
Pre-contrast-enhancement T1-weighted imaging
- T2WI:
-
T2-weighted imaging
- VOI:
-
Volume of interest
References
Ahmed M, Purushotham AD, Douek M (2014) Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol 15:e351–e362
Lyman GH, Somerfield MR, Bosserman LD et al (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35:561–564
Mamounas EP, Kuehn T, Rutgers EJT, von Minckwitz G (2017) Current approach of the axilla in patients with early-stage breast cancer. Lancet 31451-31454:S0140–S6736
Kootstra JJ, Hoekstra-Weebers JE, Rietman JS et al (2010) A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection. Ann Surg Oncol 17:2384–2394
Giuliano AE, Ballman KV, McCall L et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318:918–926
Giuliano AE, Ballman K, McCall L et al (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg 264:413–420
Galimberti V, Cole BF, Viale G et al (2018) International Breast Cancer Study Group Trial. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol 19:1385–1393
Donker M, van Tienhoven G, Straver ME et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15:1303–1310
Kim WH, Kim HJ, Lee SM et al (2019) Prediction of high nodal burden with ultrasound and magnetic resonance imaging in clinically node-negative breast cancer patients. Cancer Imaging 19:4
Dihge L, Bendahl PO, Rydén L (2017) Nomograms for preoperative prediction of axillary nodal status in breast cancer. Br J Surg 104:1494–1505
Morrow E, Lannigan A, Doughty J et al (2018) Population-based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node-positive invasive lobular carcinoma of the breast. Br J Surg 105:987–995
Youk JH, Son EJ, Kim JA, Gweon HM (2017) Preoperative evaluation of axillary lymph node status in patients with suspected breast cancer using shear wave elastography. Ultrasound Med Biol 43:1581–1586
Schipper RJ, Paiman ML, Beets-Tan RG et al (2015) Diagnostic performance of dedicated axillary T2- and diffusion-weighted MR imaging for nodal staging in breast cancer. Radiology 275:345–355
Dietzel M, Baltzer PA, Vag T et al (2010) Application of breast MRI for prediction of lymph node metastases - systematic approach using 17 individual descriptors and a dedicated decision tree. Acta Radiol 51:885–894
Dietzel M, Baltzer PA, Dietzel A et al (2010) Application of artificial neural networks for the prediction of lymph node metastases to the ipsilateral axilla - initial experience in 194 patients using magnetic resonance mammography. Acta Radiol 51:851–858
Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577
Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762
Dong Y, Feng Q, Yang W et al (2018) Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI. Eur Radiol 28:582–591
Liu C, Ding J, Spuhler K et al (2019) Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI. J Magn Reson Imaging 49:131–140
Huang YQ, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164
Ji GW, Zhang YD, Zhang H et al (2019) Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes. Radiology 290:90–98
Lester SC, Bose S, Chen YY et al (2009) Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 133:1515–1538
Giuliano AE, Connolly JL, Edge SB et al (2017) Breast cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67:290–303
Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61–70
D’Orsi CJ, Sickles EA, Mendelson EB et al (2013) ACR BI-RADS atlas. In: breast imaging reporting and data system. American College of Radiology, Reston
Michel SC, Keller TM, Fröhlich JM et al (2002) Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 225:527–536
Javid S, Segara D, Lotfi P, Raza S, Golshan M (2010) Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy. Ann Surg Oncol 17:1841–1846
Ellingson BM, Zaw T, Cloughesy TF et al (2012) Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)- MRI estimates of cerebral blood volume (CBV) in human gliomas. J Magn Reson Imaging 35:1472–1477
Zou KH, War SK, Bharatha A et al (2004) Statistical validation of image segmentation quality based on a spatial overlap index. Acad Radiol 11:178–189
Pencina MJ, D’Agostino RB, D’Agostino RB, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172
Vickers AJ, Cronin AM, Elkin EB, Gonen M (2008) Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak 8:53
Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006
Han L, Zhu Y, Liu Z et al (2019) Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer. Eur Radiol 29:3820–3829
Acknowledgements
We thank Yun Huang, Ph.D. (Sun Yat-Sen University), for her kind help with the statistical consultation.
Funding
This work was supported by Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2017), the National Natural Science Foundation of China (U1801681), the Key Areas Research and Development Program of Guangdong (2019B020235001), the Medical Artificial Intelligence Project of Sun Yat-Sen Memorial Hospital (YXRGZN201905), Natural Science Foundation of Guangdong Province (2017A030313777, 2018A030313776), and Suzhou Institute of Biomedical Engineering and Technology (#Y753181305).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Guarantor
The scientific guarantor of this publication is Jun Shen.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
We thank Yun Huang, Ph.D. (Sun Yat-Sen University), for her kind help with the statistical consultation.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained from the Institutional Review Board of Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University (Guangzhou, China) and Sun Yat-Sen Cancer Center, Sun Yat-Sen University (Guangzhou, China), respectively.
Methodology
• retrospective
• diagnostic study
• multicenter study
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 11671 kb)
Rights and permissions
About this article
Cite this article
Zhang, X., Yang, Z., Cui, W. et al. Preoperative prediction of axillary sentinel lymph node burden with multiparametric MRI-based radiomics nomogram in early-stage breast cancer. Eur Radiol 31, 5924–5939 (2021). https://doi.org/10.1007/s00330-020-07674-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-020-07674-z